Corteva, Inc. (NYSE:CTVA) Shares Sold by Cambridge Trust Co.

Cambridge Trust Co. cut its position in Corteva, Inc. (NYSE:CTVA) by 83.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,538 shares of the company’s stock after selling 7,563 shares during the period. Cambridge Trust Co.’s holdings in Corteva were worth $74,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. WCM Investment Management LLC raised its holdings in Corteva by 3.1% in the 4th quarter. WCM Investment Management LLC now owns 7,103,146 shares of the company’s stock valued at $341,590,000 after acquiring an additional 213,949 shares during the last quarter. 17 Capital Partners LLC purchased a new position in Corteva during the fourth quarter worth approximately $1,649,000. Factory Mutual Insurance Co. boosted its stake in Corteva by 10.7% during the fourth quarter. Factory Mutual Insurance Co. now owns 532,558 shares of the company’s stock worth $25,520,000 after buying an additional 51,500 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in Corteva by 9.7% in the 3rd quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 777,833 shares of the company’s stock valued at $39,794,000 after buying an additional 68,593 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Corteva by 1.1% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,760,701 shares of the company’s stock worth $132,293,000 after acquiring an additional 31,171 shares during the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Up 1.6 %

Shares of NYSE CTVA opened at $54.80 on Friday. The stock has a market cap of $38.30 billion, a P/E ratio of 53.73, a PEG ratio of 1.41 and a beta of 0.77. The business’s fifty day simple moving average is $55.23 and its 200-day simple moving average is $50.30. Corteva, Inc. has a 12-month low of $43.22 and a 12-month high of $62.10. The company has a current ratio of 1.56, a quick ratio of 0.90 and a debt-to-equity ratio of 0.09.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.09. Corteva had a return on equity of 7.43% and a net margin of 4.27%. The business had revenue of $3.71 billion during the quarter, compared to analysts’ expectations of $3.54 billion. During the same quarter last year, the business posted $0.16 EPS. As a group, equities analysts predict that Corteva, Inc. will post 2.84 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date was Thursday, February 29th. Corteva’s dividend payout ratio is presently 62.75%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CTVA shares. KeyCorp upped their price objective on shares of Corteva from $63.00 to $66.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th. Mizuho cut their price target on shares of Corteva from $59.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 1st. BNP Paribas upgraded Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price objective on the stock in a report on Friday, February 2nd. Wolfe Research started coverage on Corteva in a research note on Friday, March 1st. They set an “outperform” rating and a $67.00 target price for the company. Finally, Wells Fargo & Company upped their price target on Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $63.29.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.